EP0723458A4 - IMMUNE MODULATION BY MEANS OF CLASS II ALPHA UNIT FRAGMENTS - Google Patents

IMMUNE MODULATION BY MEANS OF CLASS II ALPHA UNIT FRAGMENTS

Info

Publication number
EP0723458A4
EP0723458A4 EP95922332A EP95922332A EP0723458A4 EP 0723458 A4 EP0723458 A4 EP 0723458A4 EP 95922332 A EP95922332 A EP 95922332A EP 95922332 A EP95922332 A EP 95922332A EP 0723458 A4 EP0723458 A4 EP 0723458A4
Authority
EP
European Patent Office
Prior art keywords
alpha
class
chain fragments
immune modulation
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95922332A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0723458A1 (en
Inventor
Carol Clayberger
Alan M Krensky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of EP0723458A1 publication Critical patent/EP0723458A1/en
Publication of EP0723458A4 publication Critical patent/EP0723458A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP95922332A 1994-06-16 1995-06-16 IMMUNE MODULATION BY MEANS OF CLASS II ALPHA UNIT FRAGMENTS Withdrawn EP0723458A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26054894A 1994-06-16 1994-06-16
US260548 1994-06-16
PCT/US1995/007673 WO1995034321A1 (en) 1994-06-16 1995-06-16 Immune modulation with class ii alpha-chain fragments

Publications (2)

Publication Number Publication Date
EP0723458A1 EP0723458A1 (en) 1996-07-31
EP0723458A4 true EP0723458A4 (en) 1998-03-11

Family

ID=22989611

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95922332A Withdrawn EP0723458A4 (en) 1994-06-16 1995-06-16 IMMUNE MODULATION BY MEANS OF CLASS II ALPHA UNIT FRAGMENTS

Country Status (5)

Country Link
EP (1) EP0723458A4 (ja)
JP (1) JPH09503003A (ja)
AU (1) AU2705795A (ja)
CA (1) CA2169762A1 (ja)
WO (1) WO1995034321A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436903B1 (en) * 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
AU7298398A (en) * 1996-11-19 1998-06-10 Sangstat Medical Corporation Enhanced effects for hapten conjugated therapeutics
AU4454700A (en) * 1999-04-12 2000-11-14 Stanford University Interaction of mhc class ii proteins with members of the pcna family of proteins
AU5697001A (en) 2000-03-31 2001-10-15 Purdue Research Foundation Method of treatment using ligand-immunogen conjugates
GB0609121D0 (en) * 2006-05-09 2006-06-21 Univ Birmingham Peptide Therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991014701A1 (en) * 1990-03-21 1991-10-03 The Board Of Trustees Of The Leland Stanford Junior University Improved major histocompatibility complex (mhc) molecules
WO1994013320A1 (en) * 1992-12-17 1994-06-23 Subramaniam Sriram Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860875D1 (en) * 1977-09-28 1981-10-15 Nat Res Dev Immunological preparations incorporating mhc antigens and their production
US5130295A (en) * 1989-01-05 1992-07-14 Consortium For Surface Processing Passivating thin film for superconducting material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991014701A1 (en) * 1990-03-21 1991-10-03 The Board Of Trustees Of The Leland Stanford Junior University Improved major histocompatibility complex (mhc) molecules
WO1994013320A1 (en) * 1992-12-17 1994-06-23 Subramaniam Sriram Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
B. AGRAWAL ET AL.: "T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.", THE JOURNAL OF IMMUNOLOGY, vol. 147, no. 2, 15 July 1991 (1991-07-15), BALTIMORE, MD, USA, pages 383 - 390, XP002050664 *
B. COHEN ET AL.: "Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 172, no. 3, 1 September 1990 (1990-09-01), NEW YORK, NY, USA, pages 779 - 788, XP002050665 *
See also references of WO9534321A1 *

Also Published As

Publication number Publication date
JPH09503003A (ja) 1997-03-25
CA2169762A1 (en) 1995-12-21
EP0723458A1 (en) 1996-07-31
AU2705795A (en) 1996-01-05
WO1995034321A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
GB2294770B (en) Induction logging
ZA959336B (en) Antibodies
ZA958634B (en) Cookware
GB2289284B (en) Alkylpolysiloxanes
SG44732A1 (en) Heat-resistant adhesive
EP0723458A4 (en) IMMUNE MODULATION BY MEANS OF CLASS II ALPHA UNIT FRAGMENTS
GB9402448D0 (en) Luminaires
HUT74862A (en) Glass
GB2292212B (en) Luminaires
GB9623639D0 (en) Laminated glass
GB9404185D0 (en) Picnic glass
GB9402593D0 (en) Antibody fragments
GB2315540B (en) Heat excahnger
CA74225S (en) Glass shade
CA74314S (en) Cooker
GB9314899D0 (en) Tumour-associated antigen
GB9408137D0 (en) Dimmer
HU9801016D0 (en) Polipeptide promoting thrombocytopoesis
GB9414132D0 (en) Put n two
GB9424481D0 (en) Drive stop
GB9414520D0 (en) Sealed drive
PL302547A1 (en) Drive
GB9424623D0 (en) Drive aasemblies
GB9406244D0 (en) Altered antibodies
GB9401597D0 (en) Altered antibodies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960301

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19980123

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000321

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020102